TITLE

Ocular changes in multi-transfused children with β-thalassaemia receiving desferrioxamine: A case-control study

AUTHOR(S)
Dewan, Pooja; Gomber, Sunil; Chawla, Hitesh; Rohatgi, Jolly
PUB. DATE
March 2011
SOURCE
South African Journal of Child Health;Mar2011, Vol. 5 Issue 1, p11
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objectives. This study was planned to determine the prevalence of ocular abnormalities in multi-transfused children with β-thalassaemia receiving desferrioxamine and to determine the association of abnormalities with the patients' age, serum ferritin level, haemoglobin concentration, and dosage and duration of treatment with desferrioxamine. Methods. Twenty-five thalassaemic children receiving desferrioxamine and attending the day-care centre of a tertiary care hospital in Delhi, India, and 25 healthy age-matched controls were examined to determine the prevalence and pattern of ocular abnormalities. A refraction test, the visual evoked response and fluorescein angiography were done where applicable. Ocular changes were correlated with serum ferritin levels, the dosage and duration of chelation with desferrioxamine, and pre-transfusion haemoglobin levels. Results. None of the children reported any visual symptoms. The prevalence of ocular abnormalities in the thalassaemic group was 36% (9/25). Ocular changes seen included cataract (5/25),blurred optic disc margins (6/25) and dilatation and tortuosity of retinal vessels (2/25). The thalassaemic children had a significantly higher prevalence of cataract than the controls (p<0.0S). Prevalence of cataract was associated with serum ferritin values above 4500 ng/ml (p<0.0S), and blurring of disc margins was significantly associated with increased duration ((5 years) and frequency ((5 times/week) of desferrioxamine administration. A positive correlation was seen between the incidence of cataract and blurred disc margins. Conclusions. Children with thalassaemia should be screened periodically for ocular abnormalities. Rational usage of desferrioxamine and use of newer chelating agents will reduce the prevalence of these abnormalities.
ACCESSION #
62095091

 

Related Articles

  • Survival and desferrioxamine in thalassaemia major. Modell, B.; Letsky, E.A.; Flynn, D.M.; Peto, R.; Weatherall, D.J. // British Medical Journal (Clinical Research Edition);4/10/1982, Vol. 284 Issue 6322, p1081 

    Investigates the survival among children with thalassemia receiving desferrioxamine in Great Britain. Prediction for an adequate dose of the medicine; Delay on the onset of hepatic fibrosis; Policy regarding the management of homozygous beta-thalassemia.

  • Establishment of a thalassaemia screening centre: An initial BMHRC experience. Shrivastava, Manisha; Chatterjee, Nirupama; Mishra, Amit; Khan, Rafiq; Soni, Ravindra // Asian Journal of Transfusion Science;Jan-Jun2008, Vol. 2 Issue 1, p26 

    Background: Thalassaemia major is an autosomal recessive genetic disorder, in which, the affected child is dependent on regular blood transfusion for its survival. Thalassaemia major children are born of normal healthy parents who are both thalassaemia minors. With around 3.5% of the population...

  • Interaction of Hb South Florida (codon 1; GTG-->ATG) and HbE, with beta-thalassemia (IVS1-1; G-->A): expression of different clinical phenotypes. Tan, Jin-Ai Mary Anne; Tan, Kim-Lian; Omar, Khairul Zaman; Chan, Lee-Lee; Wee, Yong-Chui; George, Elizabeth // European Journal of Pediatrics;Sep2009, Vol. 168 Issue 9, p1049 

    Introduction: Interactions of different hemoglobin variants with thalassemia alleles can result in various clinical phenotypes. HbE-beta-thalassemia generally manifests with severe anemia where individuals exhibit beta-thalassemia major with regular blood transfusions or...

  • Homozygous delta-beta Thalassemia in a Child: a Rare Cause of Elevated Fetal Hemoglobin. Verma, S.; Bhargava, M.; Mittal, S.; Gupta, R. // Iranian Journal of Pediatric Hematology & Oncology;Mar2013, Vol. 3 Issue 1, p222 

    Background Delta beta (δβ) thalassemia is an unusual variant of thalassemia with elevated level of fetal hemoglobin (HbF). Homozygous patients of this disorder, unlike β-thalassemia, show mild anemia. Only few cases of δβ-thalassemia have been reported from India in the available...

  • NUTRITIONAL STATUS OF THALASSEMIA MAJOR CHILDREN AND ITS IMPACT OF ON THEIR GROWTH. Saleh, Salwa M.; Salam, Hoda A. Abdel // International Journal of Academic Research;Jan2014, Vol. 6 Issue 1, p166 

    Backcround: Thalassemia, a term that defines a group of deficiencies in the production of the alpha or beta globin chain of hemoglobin, is one of the most common single gene disorders in humans. Nutritional status is becoming increasingly important. All morbidities OF thalassemc Patients can be...

  • Deferoxamine-induced dysplasia-like skeletal abnormalities at radiography and MRI. Seif El Dien, Hadeel; Esmail, Reem; Magdy, Rania; Lotfy, Hala // Pediatric Radiology;Sep2013, Vol. 43 Issue 9, p1159 

    Background: Current thalassemia major treatment includes blood transfusion and iron chelation, which is associated with growth disturbances and radiographic changes in the long bone metaphyses. Objective: To explore and discuss the spectrum of deferoxamine-induced bone-dysplasia-like changes in...

  • I'm Calm' You Yellow. Dunbar, Mark T. // Review of Optometry;2/15/2008 Part 1 of 3, Vol. 145 Issue 2, p115 

    The article presents the case of a 79-year-old white female with a yellow lesion in her right eye. Her medical examination revealed a corrected 20/20 visual acuity with reactive pupils that showed no equally afferent pupillary defect. Her dilated fundus exam showed small cups in both eyes with...

  • Transplantation of Cord-Blood Stem Cells into a Patient with Severe Thalassemia. Issaragrisil, Surapol; Visuthisakchai, Sanan; Suvatte, Vinai; Tanphaichitr, Voravarn S.; Chandanayingyong, Dasnayanee; Schreiner, Thomas; Kanokpongsakdi, Sujin; Siritanaratkul, Noppadol; Piankijagum, Anong // New England Journal of Medicine;2/9/95, Vol. 332 Issue 6, p367 

    The article presents the case study of a 2 1/2 year old girl who was diagnosed with hemoglobin E-thalassemia disease. A transplantation of cord-blood stem-cells taken from the girl's infant brother was given to the girl because the two were HLA-identical. The girl's hemoglobin levels rose after...

  • A Functional Element Necessary for Fetal Hemoglobin Silencing. Sankaran, Vijay G.; Xu, Jian; Orkin, Stuart H.; Byron, Rachel; Groudine, Mark; Bender, M.A.; Greisman, Harvey A.; Sabath, Daniel E.; Fisher, Chris; Weatherall, David J.; Premawardhena, Anuja // New England Journal of Medicine;9/1/2011, Vol. 365 Issue 9, p807 

    Background: An improved understanding of the regulation of the fetal hemoglobin genes holds promise for the development of targeted therapeutic approaches for fetal hemoglobin induction in the �-hemoglobinopathies. Although recent studies have uncovered trans-acting factors necessary for...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics